In Treatment of Type 2 diabetes mellitus Byetta 10mcg Pen is an injectable medicine that helps to control high blood glucose (sugar) levels. Lowering blood glucose levels is an essential part of managing diabetes. It helps reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Proper control of diabetes may also lessen your risk of having a heart attack or stroke. You will need to learn exactly how, where, and when to inject this insulin for it to be most effective. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
It is unsafe to consume alcohol with Byetta 10mcg Pen.
Byetta 10mcg Pen may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Byetta 10mcg Pen is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Byetta 10mcg Pen should be used with caution in patients with kidney disease. Dose adjustment of Byetta 10mcg Pen may be needed. Please consult your doctor.
Byetta 10mcg Pen is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Byetta 10mcg Pen may not be needed in these patients. Please consult your doctor.
If you miss a dose of Byetta 10mcg Pen, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More